ArticleJournal of ovarian research2026
Norepinephrine triggers ovarian granulosa cell ferroptosis via α
Article in Journal of ovarian research, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 1 paper.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
1 citing paper in PubMed.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
7 authors.
Funding
Abstract
Reduced fertility has become a global health problem. Female fertility is closely related to the normal physiological function of the ovary. Stress has been implicated in ovarian dysfunction, but the mechanisms driving this association are poorly understood. Norepinephrine (NE), a classic stress hormone, has not been extensively studied in the context of ovarian function. This study aimed to investigate the molecular mechanism of NE-induced ferroptosis in ovarian granulosa cells. Our results demonstrate that NE activates the adrenergic α1 receptor, resulting in elevated intracellular calcium levels and subsequent downregulation of FDXR gene expression. This disruption in FDXR expression dysregulates iron metabolism in the ovary, leading to iron accumulation, increased reactive oxygen species (ROS), and lipid peroxidation. These changes are accompanied by elevated levels of lipid peroxidation products, including malondialdehyde (MDA) and 4-hydroxynonenal (4-HNE). Ultimately, these processes induce mitochondrial damage, trigger ferroptosis in granulosa cells, and lead to ovarian dysfunction. These findings reveal a stress-induced pathway driving ovarian decline, suggesting α1 antagonists or FDXR modulation as therapeutic strategies.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.